Pharmaxis Ltd. announced unaudited earnings results for the second quarter and six months ended December 31, 2017. For the quarter, the company reported total revenue of AUD 2,432,000 compared to AUD 1,900,000 a year ago. Net loss before tax was AUD 15,427,000 compared to AUD 6,950,000 a year ago. Net loss after tax was AUD 15,419,000 compared to AUD 6,950,000 a year ago. Total adjusted LBITDA was AUD 14,267,000 compared to AUD 4,642,000 a year ago. Cash outflow from operations was AUD 13,023,000 compared to AUD 2,721,000 a year ago. For the six months, the company reported total revenue of AUD 31,344,000 compared to AUD 6,910,000 a year ago. Net profit before tax was AUD 5,912,000 compared to net loss after tax of AUD 11,035,000 a year ago. Net profit after tax was AUD 5,920,000 compared to net loss after tax AUD 11,035,000 a year ago. Total adjusted EBITDA was AUD 7,790,000 compared to total adjusted LBITDA of AUD 8,440,000 a year ago. Cash inflow from operations was AUD 4,639,000 compared to Cash outflow from operations AUD 8,894,000 a year ago.